Matti Adam

Interventional cardiologist / Cardiologist
Herzzentrum - Cologne, Germany

Latest contributions

Leaflet modification to prevent coronary obstruction during TAVI

22 May 2025 – From EuroPCR 2025

This session addresses advanced leaflet modification techniques to prevent coronary obstruction during TAVI. Learn from detailed cases involving valve-in-valve interventions, treatment of failed stentless valves, homograft management, and dedicated devices for leaflet modification prior to valve-in-valve and valve-in-valve-in-valve procedures.

Leaflet modification to prevent coronary obstruction during TAVI

TAVI in difficult scenarios: bicuspid anatomy and pure aortic regurgitation

22 May 2025 – From EuroPCR 2025

Address challenging TAVI scenarios involving bicuspid anatomy and pure aortic regurgitation with insights from international experiences. This session compares treatment options in China and Germany, explores anatomical and disease differences, and reviews various TAVI devices through detailed case presentations and expert commentary.

TAVI in difficult scenarios: bicuspid anatomy and pure aortic regurgitation

Emerging indications for TAVI in 2025

22 May 2025 – From EuroPCR 2025

Prepare for emerging TAVI indications anticipated in 2025. This session reviews clinical cases including asymptomatic severe aortic stenosis, moderate aortic stenosis with heart failure, and severe aortic regurgitation. It discusses supporting evidence from clinical trials, evolving transcatheter technologies, and practical treatment approaches for these novel indications.

Emerging indications for TAVI in 2025

TAVI for aortic regurgitation off label

22 May 2025 – From EuroPCR 2025

Explore off-label applications of TAVI for aortic regurgitation in complex clinical scenarios. Topics include TAV-in-SAV with Trilogy valve for severe regurgitation, challenges of transcatheter prosthesis in pure aortic regurgitation, management of surgical valve perforations, and treatment strategies in post-surgical anatomies including degenerative homografts and aortic dissection.

TAVI for aortic regurgitation off label

Future-proof your TAVI programme: increased need to enhance pathway efficiencies

21 May 2025 – From EuroPCR 2025

Explore evolving guidelines, demographic changes, and new data shaping lifetime TAVI management. Learn precision strategies to optimise patient outcomes before, during, and after TAVI, including post-procedural care and PCI with the Evolut FX+ valve. Discover practical approaches to boost hospital efficiency and embrace innovative technologies that...

Future-proof your TAVI programme: increased need to enhance pathway efficiencies

A window into the future - Expanding horizons for patients with long life expectancy with the Evolut FX + TAVI system

25 Nov 2024 – From PCR London Valves 2024

Gain insights into the key considerations when performing TAVI in patients with long life expectancy, including long-term outcomes, valve durability, and the feasibility of future redo-TAVI. Discover the latest data on TAVI in women and patients with small annulus anatomy, as well as a live case...

A window into the future - Expanding horizons for patients with long life expectancy with the Evolut

New iterations of self expendable valves - LIVE case

25 Nov 2024 – From PCR London Valves 2024

Watch a LIVE case followed by a recorded case on enhanced TAVI:

  • An 80-year-old female with severe symptomatic aortic stenosis, a complete right bundle branch block (RBB), and preserved LV function. The operators implanted a 25 mm ACURATE Prime valve following predilation with a 22 mm balloon....
New iterations of self expendable valves

TAVI for pure aortic regurgitation - LIVE case

25 Nov 2024 – From PCR London Valves 2024

Watch a LIVE case followed by a recorded case on aortic regurgitation:

  • An 86-year-old male with a history of stroke and prostate cancer presenting acute heart failure due to severe pure aortic regurgitation and LV dysfunction (EF 39%). A 27 mm JenaValve Trilogy prosthesis was implanted without...
TAVI for pure aortic regurgitation

Mitral valve replacement devices and techniques

16 May 2024 – From EuroPCR 2024

This session comprises selected EuroPCR 2024 Clinical Case submissions focused on mitral valve replacement devices and techniques. It covers various case presentations and discussions, including the treatment of mitral regurgitation with atrial fixation TMVR, mitral valve-in-valve with a novel device, transcatheter treatment of a structurally degenerated...

Mitral valve replacement devices and techniques

Innovation and strategies in TAVI: design, data and directions for clinical practice

15 May 2024 – From EuroPCR 2024

Watch this session to explore considerations for TAVI implantation in small annuli, gain insights into future lifetime management, learn about the benefits of FX technology and clinical evidence beyond small annuli, and witness a live case procedure showcasing the innovation of FX plus. This session is...

Innovation and strategies in TAVI: design, data and directions for clinical practice

TAVI in challenging anatomies

14 May 2024 – From EuroPCR 2024

Explore the complexities of TAVI in patients with intricate aortic stenosis: learn the critical role of detailed CT imaging and meticulous pre-procedural planning, and find out how to customize valve selection and implantation techniques to match unique patient anatomies, such as highly calcified tricuspid valves, low...

TAVI in challenging anatomies

Late-breaking trials: TAVI head-to-head

14 May 2024 – From EuroPCR 2024

This session presents the latest findings from several late-breaking trials comparing different transcatheter aortic valve implantation (TAVI) approaches. Topics include outcomes in women with small aortic annuli, the comparison of percutaneous versus surgical treatment for patients with aortic stenosis and coronary disease, the impact of valve...

Late-breaking trials: TAVI head-to-head

Valve in valve - TAV in TAV - Part 2

21 Nov 2023 – From PCR London Valves 2023

Join us for this session, where complex cases shed light on the evolving landscape of valve-in-valve interventions: delve into the efficacy of THV-in-THV for addressing supra-skirtal leakage accompanied by intravascular hemolysis, learn more about the challenges of TAVI-in-TAVI with the deployment of SAPIEN3 Ultra in a...

Valve in valve - TAV in TAV - Part 2

Rapid-fire - Nightmares in the cathlab - Part 2

20 Nov 2023 – From PCR London Valves 2023

TAVI in complex scenarios - Bicuspid aortic valve disease - putting it all together

20 Nov 2023 – From PCR London Valves 2023

After an overview of what is currently known about TAVI in bicuspid aortic valves, follow the analysis of a real-life clinical case, and get tips on how to perform TAVI in a bicuspid aortic valve in 3 different ways: with a self-expanding supra-annular valve, using a...

TAVI in complex scenarios - Bicuspid aortic valve disease - putting it all together

A problem and a solution: aortic regurgitation and the Trilogy TAVI valve

19 Nov 2023 – From PCR London Valves 2023

Consult this session if you want to understand the challenges of imaging for aortic regurgitation and how it can lead to underdiagnosis. Discover the data from the ALIGN-AR trial studying TAVI in aortic regurgitation patients, and learn about the Trilogy valve and the future of TAVI...

A problem and a solution: aortic regurgitation and the Trilogy TAVI valve

TAVI in complex scenarios

19 Nov 2023 – From PCR London Valves 2023

What do we mean by "complex scenarios"? When zero-contrast TAVI implantation becomes a good alternative in kidney disease, when TAVI is implanted in a patient with mechanical mitral valve, or when TAVI is implanted in very large annulus with subannular aneurysm, for example!

TAVI in complex scenarios

Tailored device choice and implant technique to optimise TAVI procedural outcomes

17 May 2023 – From EuroPCR 2023

Discover the key factors to consider in selecting the optimal valve and implant technique for transcatheter aortic valve implantation (TAVI) to achieve optimal procedural outcomes. Gain insights into the impact of device choice and implantation technique on coronary access following TAVI and learn valuable strategies for...

Clinical outcomes after TAVI: Session 2

29 Nov 2022 – From PCR London Valves 2022

Consult this session on the clinical outcomes after TAVI to learn more about the first results after commercial TAVI utilising the JenaValve Trilogy system for aortic stenosis and aortic regurgitation, the outcomes of contrast-zero TAVI vs. standard practice in patients with severe renal dysfunction, and more!

Clinical outcomes after TAVI: Session 2

Technical challenges and optimal device choice for complex TAVI procedures

28 Nov 2022 – From PCR London Valves 2022

This session reflects on the importance of device choice and implantation technique in complex TAVI procedures. Learn how to anticipate the risks of a valve-in-valve procedure in small surgical prostheses, and discover the latest technological evolutions for treating patients with complex anatomy.

The role of coronary interventionalist in TAVI - From referral to timing of PCI

19 May 2022 – From EuroPCR 2022

Consult this session to learn how to contribute to streamlined pre- and post-TAVI patient pathways, to discover updates on the optimised TAVI procedure and appreciate the variances in different valve designs and the long-term patient outcomes, as well as to discuss the right time of PCI in TAVI patients...

EuroPCR 2022 Early experience and registry results in TAVI: Optimize PRO, FORWARD PRO, Neo-Align, and more!

17 May 2022 – From EuroPCR 2022

Find out more about various studies & registries in TAVI! ACURATE neo2 post-procedural hemodynamic outcomes, first real-world results of the JenaValve TAVI system, Optimize PRO study, a next-generation aortic transcatheter heart valve, commissural alignment, and three-year outcomes following TAVI with a self-expanding valve with pericardial wrap.

EuroPCR 2022 Hotlines / Late-Breaking Trials in TAVI: Optimize PRO, FORWARD PRO, Neo-Align, and more!

TAVI: the future

22 Nov 2021 – From PCR London Valves 2021

This session from PCR London Valves 2021 particularly focuses on the expected expansions of TAVI to patients at a younger age and with a longer life expectancy, including a virtual live case from Clinique Pasteur, Toulouse, France.

TAVI: the future

A new evolution: TAVR for aortic regurgitation with the JenaValve Trilogy System

22 Nov 2021 – From PCR London Valves

Watch this session released during PCR London Valves 2021 Congress to have a deep dive into aortic regurgitation: the natural history, the clinical reality of it, and a fantastic live recorded case, so as to gain deeper understanding of the progression of severe aortic regurgitation, to learn more...

A new evolution: TAVR for aortic regurgitation with the JenaValve Trilogy System

PCR London Valves 2021 Hotlines / Late-Breaking Trials: GALILEO, JenaValve TAVI, ENVISAGE TAVI AF, VKA in patients with AF after TAVI

21 Nov 2021 – From PCR London Valves 2021

In this session, find out more about the JenaValve TAVI system in patients with aortic regurgitation, get results from the GALILEO trial, review a late-breaking on-treatment major bleeding analysis from the ENVISAGE TAVI AF trial, and explore the safety and efficacy of edoxaban versus VKA in patients with AF...

PCR London Valves 2021 Hotlines / Late-Breaking Trials: GALILEO, JenaValve TAVI,, ENVISAGE TAVI AF, VKA in patients with AF after TAVI